Expression and molecular profiles of the AlkB family in ovarian serous carcinoma

被引:3
|
作者
Cai, Yuan [1 ]
Wu, Geting [1 ]
Peng, Bi [1 ]
Li, Juanni [1 ]
Zeng, Shuangshuang [2 ]
Yan, Yuanliang [2 ]
Xu, Zhijie [1 ,3 ]
机构
[1] Cent South Univ, Xiangya Hosp, Dept Pathol, Changsha 410008, Hunan, Peoples R China
[2] Cent South Univ, Xiangya Hosp, Dept Pharm, Changsha 410008, Hunan, Peoples R China
[3] Cent South Univ, Xiangya Hosp, Natl Clin Res Ctr Geriatr Disorders, Changsha 410008, Hunan, Peoples R China
来源
AGING-US | 2021年 / 13卷 / 07期
基金
中国国家自然科学基金; 中国博士后科学基金;
关键词
ovarian serous carcinoma; AlkB family; expression profiles; infiltrating immune cells; methylation; CANCER PROGRESSION; M(6)A;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
AlkB family of Fe (II) and alpha-ketoglutarate-dependent dioxygenases plays essential roles in development of ovarian serous carcinoma (OV). However, the molecular profiles of AlkB family in OV have not been clarified. The results indicated that the expression of ALKBH1/3/5/8 and FTO was lower in OV patients while ALKBH2/4/6/7 expression was higher. There was a strong correlation between ALKBH5/7 and pathological stage of OV patients. KaplanMeier plotter revealed that OV patients with high ALKBH4 level showed longer overall survival (OS). However, patients with high levels of ALKBH5/6 and FTO showed shorter OS and progression-free survival (PFS). Genetic alterations using cBioPortal revealed that the alteration rates of FTO were the highest. We also found that the functions of AlkB family were linked to several cancer-associated signaling pathways, including chemokine receptor signaling. TIMER database indicated that the AlkB family had a strong relationship with the infiltration of six types of immune cells (macrophages, neutrophils, CD8+ T-cells, B-cells, CD4+ T-cells and dendritic cells). Next, DiseaseMeth databases revealed that the global methylation levels of ALKBH1/2/3/4/5/6/7/8 and FTO were all lower in OV patients. Thus, our findings will enhance the understanding of AlkB family in OV pathology, and provide novel insights into AlkB-targeted therapy for OV patients.
引用
收藏
页码:9679 / 9692
页数:14
相关论文
共 50 条
  • [41] Determining the molecular profile of low grade serous ovarian carcinoma (LGSOC)
    Ilenkovan, N.
    Evans, M.
    Wang, D.
    Gourley, C.
    Herrington, C. S.
    Thomson, J.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2020, 127 (08) : E59 - E60
  • [42] Consensus on Molecular Subtypes of High-Grade Serous Ovarian Carcinoma
    Chen, Gregory M.
    Kannan, Lavanya
    Geistlinger, Ludwig
    Kofia, Victor
    Safikhani, Zhaleh
    Gendoo, Deena M. A.
    Parmigiani, Giovanni
    Birrer, Michael
    Haibe-Kains, Benjamin
    Waldron, Levi
    CLINICAL CANCER RESEARCH, 2018, 24 (20) : 5037 - 5047
  • [43] HER4 Expression and Overall Survival in Ovarian Serous Carcinoma
    Strosberg, Carolina
    Wenham, Robert M.
    Hakam, Ardeshir
    Magliocco, Anthony M.
    Saglam, Ozlen
    MODERN PATHOLOGY, 2016, 29 : 312A - 312A
  • [44] PD-L1 expression in serous ovarian carcinoma with calcification
    Chyzhma, R.
    Moskalenko, R.
    VIRCHOWS ARCHIV, 2024, 485 : S279 - S279
  • [45] MiRNA expression signature for potentially predicting the prognosis of ovarian serous carcinoma
    Yu, Xiaotang
    Zhang, Xinchen
    Bi, Tie
    Ding, Yanfang
    Zhao, Jinyao
    Wang, Chang
    Jia, Tingting
    Han, Dan
    Guo, Gordon
    Wang, Bo
    Jiang, Jiyong
    Cui, Shiying
    TUMOR BIOLOGY, 2013, 34 (06) : 3501 - 3508
  • [46] Apolipoprotein E expression in ovarian serous carcinoma and other types of cancer
    Cheng, CC
    Chen, YC
    Maitra, A
    Hruban, R
    Gabrison, E
    Korman, RJ
    Shih, IM
    LABORATORY INVESTIGATION, 2003, 83 (01) : 186A - 186A
  • [47] Placental type alkaline phosphatase tissue expression in ovarian serous carcinoma
    Orsaria, Maria
    Londero, Ambrogio P.
    Marzinotto, Stefania
    Di Loreto, Carla
    Marchesoni, Diego
    Mariuzzi, Laura
    CANCER BIOMARKERS, 2016, 17 (04) : 479 - 486
  • [48] Genetic alterations and protein expression of KIT and PDGFRA in serous ovarian carcinoma
    H Lassus
    H Sihto
    A Leminen
    S Nordling
    H Joensuu
    N N Nupponen
    R Butzow
    British Journal of Cancer, 2004, 91 : 2048 - 2055
  • [49] Genetic alterations and protein expression of KIT and PDGFRA in serous ovarian carcinoma
    Lassus, H
    Sihto, H
    Leminen, A
    Nordling, S
    Joensuu, H
    Nupponen, NN
    Butzow, R
    BRITISH JOURNAL OF CANCER, 2004, 91 (12) : 2048 - 2055
  • [50] HER4 Expression and Overall Survival in Ovarian Serous Carcinoma
    Strosberg, Carolina
    Wenham, Robert M.
    Hakam, Ardeshir
    Magliocco, Anthony M.
    Saglam, Ozlen
    LABORATORY INVESTIGATION, 2016, 96 : 312A - 312A